ATE41603T1 - Pharmazeutische formulierung mit gehalt an azapropazone. - Google Patents

Pharmazeutische formulierung mit gehalt an azapropazone.

Info

Publication number: ATE41603T1
Authority: AT; Austria
Prior art keywords: azapropazone; pharmaceutical formulation; formulation containing; carboxylate; molar ratio
Prior art date: 1984-03-08

Application number

AT85301395T

Other languages

English (en)

Inventor

Kim Drummond Rainsford

Michael Wellesley Whitehouse

Original Assignee

Kim Drummond Rainsford

Whitehouse Michael W

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-03-08

Filing date

1985-02-28

Publication date

1989-04-15

1985-02-28 Application filed by Kim Drummond Rainsford, Whitehouse Michael W filed Critical Kim Drummond Rainsford

1989-04-15 Application granted granted Critical

1989-04-15 Publication of ATE41603T1 publication Critical patent/ATE41603T1/de

Links

WOIIIUDZSOLAIW-NSHDSACASA-N azapropazone Chemical compound C1=C(C)C=C2N3C(=O)[C@H](CC=C)C(=O)N3C(N(C)C)=NC2=C1 WOIIIUDZSOLAIW-NSHDSACASA-N 0.000 title abstract 4
229960001671 azapropazone Drugs 0.000 title abstract 4
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
150000001720 carbohydrates Chemical class 0.000 abstract 2
150000007942 carboxylates Chemical class 0.000 abstract 2
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
229910052783 alkali metal Inorganic materials 0.000 abstract 1
150000001340 alkali metals Chemical class 0.000 abstract 1
229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
150000001342 alkaline earth metals Chemical class 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT85301395T 1984-03-08 1985-02-28 Pharmazeutische formulierung mit gehalt an azapropazone. ATE41603T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB08406055A GB2155329A (en)	1984-03-08	1984-03-08	A pharmaceutical formulation containing azapropazone
EP85301395A EP0154523B1 (de)	1984-03-08	1985-02-28	Pharmazeutische Formulierung mit Gehalt an Azapropazone

Publications (1)

Publication Number	Publication Date
ATE41603T1 true ATE41603T1 (de)	1989-04-15

Family

ID=10557766

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT85301395T ATE41603T1 (de)	1984-03-08	1985-02-28	Pharmazeutische formulierung mit gehalt an azapropazone.

Country Status (15)

Country	Link
US (1)	US5034379A (de)
EP (1)	EP0154523B1 (de)
JP (1)	JPS60215635A (de)
AT (1)	ATE41603T1 (de)
AU (1)	AU572968B2 (de)
CA (1)	CA1256803A (de)
DE (1)	DE3568943D1 (de)
DK (1)	DK106485A (de)
ES (1)	ES8800598A1 (de)
GB (1)	GB2155329A (de)
NO (1)	NO850913L (de)
NZ (1)	NZ211294A (de)
PH (1)	PH21053A (de)
PT (1)	PT80078B (de)
ZA (1)	ZA851642B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4668676A (en) *	1985-12-06	1987-05-26	E.I. Du Pont De Nemours And Company	Azapropazone prevention of post-ischemic tissue damage
GB8607662D0 (en) *	1986-03-27	1986-04-30	Rainsford K D	Pharmaceutical formulation
EP0278997A1 (de) *	1987-02-17	1988-08-24	Siegfried Aktiengesellschaft	Azapropazon-Rektalkapseln
US5229374A (en) *	1992-01-28	1993-07-20	Burton Albert F	Method for treatment of lower gastrointestinal tract disorders
WO1993018775A1 (en) *	1992-03-19	1993-09-30	The University Of British Columbia	Method and composition for suppression of side effects of anti-inflammatory drugs
AU4055993A (en) *	1992-05-15	1993-12-13	University Of British Columbia, The	N-acetyl glucosamine as gastroprotective agent
GB9321655D0 (en) *	1993-10-20	1993-12-08	Glyzinc Pharma Ltd	Pharmaceutical formulation of aspirin and salicylates
FR2836656B1 (fr) *	2002-03-01	2004-05-28	Michelin Soc Tech	Dispositif et procede de traitement des phenomenes de perte de pression et de roulage a plat des pneumatiques d'un vehicule

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU511852B2 (en) *	1977-11-09	1980-09-11	Australian National University, The	Formulating aspirin andthe like
EP0013783B1 (de) *	1979-01-12	1984-04-04	The Australian National University	Schutz der Magenschleimhaut vor Beschädigung durch Aspirin und verwandte Arzneimittel
EP0028660B1 (de) *	1979-11-10	1985-10-23	Siegfried Aktiengesellschaft	Xanthinoxydasehemmer und Verwendung von Benztriazinderivaten

1984
- 1984-03-08 GB GB08406055A patent/GB2155329A/en not_active Withdrawn
1985
- 1985-02-28 EP EP85301395A patent/EP0154523B1/de not_active Expired
- 1985-02-28 AT AT85301395T patent/ATE41603T1/de not_active IP Right Cessation
- 1985-02-28 DE DE8585301395T patent/DE3568943D1/de not_active Expired
- 1985-03-04 CA CA000475656A patent/CA1256803A/en not_active Expired
- 1985-03-04 NZ NZ211294A patent/NZ211294A/en unknown
- 1985-03-05 ZA ZA851642A patent/ZA851642B/xx unknown
- 1985-03-05 AU AU39506/85A patent/AU572968B2/en not_active Ceased
- 1985-03-06 PH PH31950A patent/PH21053A/en unknown
- 1985-03-06 JP JP60044494A patent/JPS60215635A/ja active Pending
- 1985-03-07 PT PT80078A patent/PT80078B/pt not_active IP Right Cessation
- 1985-03-07 NO NO850913A patent/NO850913L/no unknown
- 1985-03-07 ES ES541054A patent/ES8800598A1/es not_active Expired
- 1985-03-08 DK DK106485A patent/DK106485A/da not_active Application Discontinuation
1989
- 1989-06-19 US US07/368,100 patent/US5034379A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0154523A2 (de)	1985-09-11
ES541054A0 (es)	1987-11-16
NZ211294A (en)	1987-09-30
PT80078B (en)	1987-02-23
DK106485D0 (da)	1985-03-08
ZA851642B (en)	1985-10-30
EP0154523B1 (de)	1989-03-22
PH21053A (en)	1987-07-03
DE3568943D1 (en)	1989-04-27
US5034379A (en)	1991-07-23
ES8800598A1 (es)	1987-11-16
NO850913L (no)	1985-09-09
GB8406055D0 (en)	1984-04-11
JPS60215635A (ja)	1985-10-29
DK106485A (da)	1985-09-09
PT80078A (en)	1985-04-01
GB2155329A (en)	1985-09-25
CA1256803A (en)	1989-07-04
AU572968B2 (en)	1988-05-19
EP0154523A3 (en)	1986-06-04
AU3950685A (en)	1985-09-12

Legal Events

Date	Code	Title	Description
1989-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ES2072392T3 (es)	1995-07-16	Composicion blanqueante.
DE69804493D1 (de)	2002-05-02	Schweisshemmendes mittel mit dibenzylidensorbitol
DE69011399D1 (de)	1994-09-15	Stabile flüssige Formulierung von 5-Aminosalizylsäure.
FI854167L (fi)	1986-04-26	Mun- och tandvaordsmedel.
ATE41603T1 (de)	1989-04-15	Pharmazeutische formulierung mit gehalt an azapropazone.
FR2666508B1 (fr)	1994-02-18	Compositions pharmaceutiques contenant des derives de furanne.
DE58905187D1 (de)	1993-09-09	Zubereitungen des oxipurinols und/oder seiner alkali- oder erdalkalisalze.
ES2061829T3 (es)	1994-12-16	Solucion acuosa, estable frente al almacenamiento, de alquiltrialcoxisilanos.
NZ232511A (en)	1991-01-29	Acetate buffer-stabilised pentamidine (1,5-bis(4-amidinophenoxy)pentane) solutions
ATE74383T1 (de)	1992-04-15	Entchlorung waesseriger alkalimetallchloridloesungen.
TR23253A (tr)	1989-07-31	Zorunlu olarak sodyum suelfat meydana gelmeden parafin-sulfoksidasyon-reaksiyon karisimlarindan alkali suelfat bakimindan fakir parafin suelfonot'larinin ve suelfuerik asidin izde edilmesine mahsus usul
DE3673099D1 (de)	1990-09-06	Alkalivertraegliche amphoterische sulfobetain-tenside.
SE7613849L (sv)	1977-06-13	For injicering ferdigstellda losningar
EP0351809A3 (de)	1991-10-30	Blutgerinnungshemmendes Mittel
DE68905178D1 (de)	1993-04-08	Stabile waessrige zubereitung von aktivem vitamin-d-3.
DE3780353D1 (de)	1992-08-20	Waesserige loesungen harzartiger verbindungen.
GB1216131A (en)	1970-12-16	Stable, aqueous nystatin preparations